Global Betrixaban API Market Research Report 2025

Publication ID:

PB502255560

Publication Date:

February 7, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

The global market for Betrixaban API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Betrixaban听(trade name听Bevyxxa) is an oral听anticoagulant听drug which acts as a听direct factor Xa inhibitor
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Betrixaban API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Betrixaban API.
The Betrixaban API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Betrixaban API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Betrixaban API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hovione
Viatris
LGM Pharma
Jigs Chemical
Coba Pharma
Cckinase
Biosynth
BOC Sciences
Avanscure Lifesciences
Apexbio Technology
Adooq Bioscience
MSN Labs
Nifty Labs
Hetero Drugs
Symed Labs
by Type
0.99
0.98
by Application
Pharmaceutical
Scientific Research
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Betrixaban API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Betrixaban API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Betrixaban API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Betrixaban API Market Overview
1.1 Product Definition
1.2 Betrixaban API by Type
1.2.1 Global Betrixaban API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 0.99
1.2.3 0.98
1.3 Betrixaban API by Application
1.3.1 Global Betrixaban API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Pharmaceutical
1.3.3 Scientific Research
1.4 Global Market Growth Prospects
1.4.1 Global Betrixaban API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Betrixaban API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Betrixaban API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Betrixaban API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Betrixaban API Production Market Share by Manufacturers (2020-2025)
2.2 Global Betrixaban API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Betrixaban API, Industry Ranking, 2023 VS 2024
2.4 Global Betrixaban API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Betrixaban API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Betrixaban API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Betrixaban API, Product Offered and Application
2.8 Global Key Manufacturers of Betrixaban API, Date of Enter into This Industry
2.9 Betrixaban API Market Competitive Situation and Trends
2.9.1 Betrixaban API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Betrixaban API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Betrixaban API Production by Region
3.1 Global Betrixaban API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Betrixaban API Production Value by Region (2020-2031)
3.2.1 Global Betrixaban API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Betrixaban API by Region (2026-2031)
3.3 Global Betrixaban API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Betrixaban API Production Volume by Region (2020-2031)
3.4.1 Global Betrixaban API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Betrixaban API by Region (2026-2031)
3.5 Global Betrixaban API Market Price Analysis by Region (2020-2025)
3.6 Global Betrixaban API Production and Value, Year-over-Year Growth
3.6.1 North America Betrixaban API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Betrixaban API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Betrixaban API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Betrixaban API Production Value Estimates and Forecasts (2020-2031)
4 Betrixaban API Consumption by Region
4.1 Global Betrixaban API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Betrixaban API Consumption by Region (2020-2031)
4.2.1 Global Betrixaban API Consumption by Region (2020-2025)
4.2.2 Global Betrixaban API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Betrixaban API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Betrixaban API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Betrixaban API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Betrixaban API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Betrixaban API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Betrixaban API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Betrixaban API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Betrixaban API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Betrixaban API Production by Type (2020-2031)
5.1.1 Global Betrixaban API Production by Type (2020-2025)
5.1.2 Global Betrixaban API Production by Type (2026-2031)
5.1.3 Global Betrixaban API Production Market Share by Type (2020-2031)
5.2 Global Betrixaban API Production Value by Type (2020-2031)
5.2.1 Global Betrixaban API Production Value by Type (2020-2025)
5.2.2 Global Betrixaban API Production Value by Type (2026-2031)
5.2.3 Global Betrixaban API Production Value Market Share by Type (2020-2031)
5.3 Global Betrixaban API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Betrixaban API Production by Application (2020-2031)
6.1.1 Global Betrixaban API Production by Application (2020-2025)
6.1.2 Global Betrixaban API Production by Application (2026-2031)
6.1.3 Global Betrixaban API Production Market Share by Application (2020-2031)
6.2 Global Betrixaban API Production Value by Application (2020-2031)
6.2.1 Global Betrixaban API Production Value by Application (2020-2025)
6.2.2 Global Betrixaban API Production Value by Application (2026-2031)
6.2.3 Global Betrixaban API Production Value Market Share by Application (2020-2031)
6.3 Global Betrixaban API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Hovione
7.1.1 Hovione Betrixaban API Company Information
7.1.2 Hovione Betrixaban API Product Portfolio
7.1.3 Hovione Betrixaban API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Hovione Main Business and Markets Served
7.1.5 Hovione Recent Developments/Updates
7.2 Viatris
7.2.1 Viatris Betrixaban API Company Information
7.2.2 Viatris Betrixaban API Product Portfolio
7.2.3 Viatris Betrixaban API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Viatris Main Business and Markets Served
7.2.5 Viatris Recent Developments/Updates
7.3 LGM Pharma
7.3.1 LGM Pharma Betrixaban API Company Information
7.3.2 LGM Pharma Betrixaban API Product Portfolio
7.3.3 LGM Pharma Betrixaban API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 LGM Pharma Main Business and Markets Served
7.3.5 LGM Pharma Recent Developments/Updates
7.4 Jigs Chemical
7.4.1 Jigs Chemical Betrixaban API Company Information
7.4.2 Jigs Chemical Betrixaban API Product Portfolio
7.4.3 Jigs Chemical Betrixaban API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Jigs Chemical Main Business and Markets Served
7.4.5 Jigs Chemical Recent Developments/Updates
7.5 Coba Pharma
7.5.1 Coba Pharma Betrixaban API Company Information
7.5.2 Coba Pharma Betrixaban API Product Portfolio
7.5.3 Coba Pharma Betrixaban API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Coba Pharma Main Business and Markets Served
7.5.5 Coba Pharma Recent Developments/Updates
7.6 Cckinase
7.6.1 Cckinase Betrixaban API Company Information
7.6.2 Cckinase Betrixaban API Product Portfolio
7.6.3 Cckinase Betrixaban API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Cckinase Main Business and Markets Served
7.6.5 Cckinase Recent Developments/Updates
7.7 Biosynth
7.7.1 Biosynth Betrixaban API Company Information
7.7.2 Biosynth Betrixaban API Product Portfolio
7.7.3 Biosynth Betrixaban API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Biosynth Main Business and Markets Served
7.7.5 Biosynth Recent Developments/Updates
7.8 BOC Sciences
7.8.1 BOC Sciences Betrixaban API Company Information
7.8.2 BOC Sciences Betrixaban API Product Portfolio
7.8.3 BOC Sciences Betrixaban API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 BOC Sciences Main Business and Markets Served
7.8.5 BOC Sciences Recent Developments/Updates
7.9 Avanscure Lifesciences
7.9.1 Avanscure Lifesciences Betrixaban API Company Information
7.9.2 Avanscure Lifesciences Betrixaban API Product Portfolio
7.9.3 Avanscure Lifesciences Betrixaban API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Avanscure Lifesciences Main Business and Markets Served
7.9.5 Avanscure Lifesciences Recent Developments/Updates
7.10 Apexbio Technology
7.10.1 Apexbio Technology Betrixaban API Company Information
7.10.2 Apexbio Technology Betrixaban API Product Portfolio
7.10.3 Apexbio Technology Betrixaban API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Apexbio Technology Main Business and Markets Served
7.10.5 Apexbio Technology Recent Developments/Updates
7.11 Adooq Bioscience
7.11.1 Adooq Bioscience Betrixaban API Company Information
7.11.2 Adooq Bioscience Betrixaban API Product Portfolio
7.11.3 Adooq Bioscience Betrixaban API Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Adooq Bioscience Main Business and Markets Served
7.11.5 Adooq Bioscience Recent Developments/Updates
7.12 MSN Labs
7.12.1 MSN Labs Betrixaban API Company Information
7.12.2 MSN Labs Betrixaban API Product Portfolio
7.12.3 MSN Labs Betrixaban API Production, Value, Price and Gross Margin (2020-2025)
7.12.4 MSN Labs Main Business and Markets Served
7.12.5 MSN Labs Recent Developments/Updates
7.13 Nifty Labs
7.13.1 Nifty Labs Betrixaban API Company Information
7.13.2 Nifty Labs Betrixaban API Product Portfolio
7.13.3 Nifty Labs Betrixaban API Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Nifty Labs Main Business and Markets Served
7.13.5 Nifty Labs Recent Developments/Updates
7.14 Hetero Drugs
7.14.1 Hetero Drugs Betrixaban API Company Information
7.14.2 Hetero Drugs Betrixaban API Product Portfolio
7.14.3 Hetero Drugs Betrixaban API Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Hetero Drugs Main Business and Markets Served
7.14.5 Hetero Drugs Recent Developments/Updates
7.15 Symed Labs
7.15.1 Symed Labs Betrixaban API Company Information
7.15.2 Symed Labs Betrixaban API Product Portfolio
7.15.3 Symed Labs Betrixaban API Production, Value, Price and Gross Margin (2020-2025)
7.15.4 Symed Labs Main Business and Markets Served
7.15.5 Symed Labs Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Betrixaban API Industry Chain Analysis
8.2 Betrixaban API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Betrixaban API Production Mode & Process Analysis
8.4 Betrixaban API Sales and Marketing
8.4.1 Betrixaban API Sales Channels
8.4.2 Betrixaban API Distributors
8.5 Betrixaban API Customer Analysis
9 Betrixaban API Market Dynamics
9.1 Betrixaban API Industry Trends
9.2 Betrixaban API Market Drivers
9.3 Betrixaban API Market Challenges
9.4 Betrixaban API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Hovione
Viatris
LGM Pharma
Jigs Chemical
Coba Pharma
Cckinase
Biosynth
BOC Sciences
Avanscure Lifesciences
Apexbio Technology
Adooq Bioscience
MSN Labs
Nifty Labs
Hetero Drugs
Symed Labs

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂